Navigation Links
MIT develops a 'paper towel' for oil spills
Date:5/30/2008

ting above the boiling point of oil. The oil evaporates, and can be condensed back into a liquid. The membrane-and oil-can be used again.

Two key properties make the system work. First, the nanowires form a spaghetti-like mat with many tiny pores that make for good capillarity, or the ability to absorb liquids. Second, a water-repelling coating keeps water from penetrating into the membrane. Oil, however, isn't affected, and seeps into the membrane.

The membrane is created by the same general technique as its low-tech cousin, paper. We make a suspension of nanowires, like a suspension of cellulose [the key component of paper], dry it on a non-sticking plate, and we get pretty much the same results, Stellacci said.

In a commentary accompanying the Nature Nanotechnology paper, Joerg Lahann of the University of Michigan concluded: Stellacci and co-workers have provided an example of a nanomaterial that has been rationally designed to address a major environmental challenge.


'/>"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Bio Career Center Develops New Tool to Assist in Employer/Candidate Match
2. A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy
3. Team develops energy-efficient microchip
4. NIST develops test method for key micromechanical property
5. NIST team develops novel method for nanostructured polymer thin films
6. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
7. National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients
8. White Paper Details New Techniques for Isolating, Identifying Anaerobic Bacteria and Organisms
9. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
10. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
11. PNAS paper and its authors honored for scientific excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Japan , April 16, 2015  Center ... University and Takeda Pharmaceutical Company Limited (Takeda) announced ... clinical applications of induced pluripotent stem cells in ... disorders and cancer immunotherapy. The "Takeda-CiRA Joint Program ... expedite multiple research projects for drug discovery and ...
(Date:4/16/2015)... Proove Biosciences , Inc. is pleased to ... for the 2015 BIO International Convention. Hosted by the ... will take place June 15-18 at the Pennsylvania Convention ... contest, industry leaders will be voting for companies they ... community voting period began on April 14, 2015 and ...
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
... a Tool to Make Soyfoods Even HealthierST. LOUIS, March ... healthcare professionals believe soy to be beneficial to the ... method to make food products such as soyfoods even ... Biotechnology Awareness & Attitude Survey - sponsored by ...
... cell line manufacturing, Selexis is now offering a ... drugs with added characterization servicesGENEVA, March 31 ... and services for the rapid development of high-performance ... offering focusing on the biosimilar market segment. ...
... March 31 Sigma-Aldrich (Nasdaq: ... quality services and oligonucleotides to Gene Oracle, an innovative ... agreement, Sigma-Aldrich will be the exclusive supplier of custom ... engage in co-marketing efforts to promote the GeneIOS system ...
Cached Biology Technology:Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 3Selexis Launches Biosimilar Cell Line Development Program 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 3
(Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... study of more than 68,000 infants published in this ... Rotateq demonstrated that it can safely prevent 98 percent ... account for 2 million hospital visits and 500,000 pediatric ... largest pre-licensure vaccine clinical trials ever conducted worldwide, research ...
... against the Epstein-Barr virus, the virus that most often ... sclerosis 15 to 20 years later, according to a ... June 2006 print issue of Archives of Neurology, one ... that external factors may influence the risk for multiple ...
... called statins do not appear to reduce the incidence ... of previous studies in the January 4 issue of ... the risk of developing cancer, the authors provide as ... been studied in numerous large-scale, randomized, active- or placebo-controlled ...
Cached Biology News:New vaccine for condition that kills 500,000 children a year 2New vaccine for condition that kills 500,000 children a year 3Epstein-Barr virus may be associated with multiple sclerosis 2Statins have neutral effect on risk of cancer 2
Mouse Anti-Lamin B...
Hybridization Buffer 3.6 ml...
Chicken polyclonal to Thaumatin 2 ( Abpromise for all tested applications). Antigen: Full length Thaumatin 2...
Proteinase K Buffer 3.9 ml...
Biology Products: